Sanofi Aventis

• 

  Sanofi India Sells Building in Mumbai

  Drug firm Sanofi India has sold its commercial property, land and a building known as 'Aventis House' in Mumbai, for Rs 111 crore.

• Price Cap: Drug Makers' Profitability May Come Under Pressure, Says Icra

  With the drug price control order (DPCO) coverage extending to almost 40 per cent of the industry, profitability in the domestic business of pharma companies is likely to come under pressure, according to rating agency Icra.

• US regulators give nod to Lupin for tuberculosis drug

  Drug major Lupin today said it has received US health regulator's approval to market a generic version of Sanofi Aventis' Rifadin capsules, used to treat tuberculosis, in the American market.

• Sanofi Aventis not liable to pay tax for Shantha Biotechnics deal: High Court

  The Andhra Pradesh High Court has ruled that French drug multinational Sanofi Aventis will not have to pay taxes in India for a deal with Hyderabad-based vaccine firm Shantha Biotechnics.

• Dr Reddy's, Sun Pharma get US regulator nod for heart disease drug

  Clopidogrel tablets are the generic version of Sanofi Aventis' Plavix tablets.

• Sanofi Aventis to revamp its product launch strategy

  French drugmaker Sanofi Aventis is breaking away from the strategy followed by most MNC pharma companies when it comes to rural marketing. After the launch of its rural maket initiative Prayas, it is  looking at revamping its product launch strategy. The company now feels a focussed approach on fewer Hoechst prodcuts will help develop ...

• Asian stocks up on big US-French drug merger

  Asian stock markets were higher in early trading Thursday as investors took heart from a major U.S.-French pharmaceutical merger and a raft of strong U.S. corporate earnings. The Nikkei 225 stock average added 73.86 points, 0.7 percent, to 10,882.15. Australia's S&P/ASX 200 was up 0.2 percent at 5,027.50. South Korea's Kospi index increased...

• Aventis Pharma surges by 6% on BSE

  Shares of Aventis Pharma rose by nearly 6 per cent in early trade on the BSE on Thursday, boosted by an over four-fold jump in net profit for the quarter ended December 31, 2010. The company on Wednesday posted an over four-fold increase in net profit to Rs 104.9 crore for the three-month period ended December 31, 2010. The board of the pha...